Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Antipsychotic polypharmacy in schizophrenia in Canada

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Antipsychotic polypharmacy in schizophrenia in Canada. Pharmacoecon. Outcomes News 321, 9 (2001). https://doi.org/10.1007/BF03269472

    Download citation

    Keywords

    • Schizophrenia
    • Risperidone
    • Olanzapine
    • Outcome News
    • Tertiary Care